Since endothelial dysfunction is one of the mechanisms involved in stroke pathogenesis in CKD, therapy to reduce endothelial dysfunction such as statins, angiotensin-converting enzyme (ACE) inhibitors, phosphodiesterase inhibitors (such as cilostazol and dipyridamole) to enhance nitric oxide release can be helpful. Here, ACE is linked to stroke disorder.